期刊文献+

妊娠滋养细胞疾病的分子生物学研究进展 被引量:2

原文传递
导出
摘要 妊娠滋养细胞疾病是来源于胎盘滋养细胞的一组疾病,包括葡萄胎,侵蚀性葡萄胎,绒毛膜癌,胎盘部位滋养细胞肿瘤,是对女性健康带来严重威胁的疾病之一。其发生发展是多因素参与的极其复杂的病理过程,因而引起了国内外学者的广泛关注,现就其分子生物学研究进展进行综述。
出处 《中国妇幼保健》 CAS 北大核心 2014年第6期967-969,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献3

二级参考文献36

  • 1Lim LP,Lau NC,Garrett-Engele P,et al.Microarray analysis showsthat some microRNAs downregulate large numbers of target mRNAs[J].Nature,2005,433(7027):769-773.
  • 2Bommer GT,Gerin I,Feng Y,et al.p53-Mediated activation ofmiRNA34 candidate tumor-suppressor genes[J].Curr Biol,2007,17(15):1298-1307.
  • 3Chang TC,Wentzel EA,Kent OA,et al.Transactivation of miR-34aby p53 broadly influences gene expression and promotes apoptosis[J].Mol Cell,2007,26(5):745-752.
  • 4He L,He X,Lim LP,et al.A microRNA component of the p53 tumoursuppressor network[J].Nature,2007,447(7148):1130-1134.
  • 5Raver-Shapira N,Marciano E,Meiri E,et al.Transcriptional activa-tion of miR-34a contributes to p53-mediated apoptosis[J].MolCell,2007,26(5):731-743.
  • 6Tarasov V,Jung P,Verdoodt B,et al.Differential regulation of mi-croRNAs by p53 revealed by massively parallel sequencing:miR-34a is a p53 target that induces apoptosis and G1-arrest[J].CellCycle,2007,6(13):1586-1593.
  • 7Welch C,Chen Y,Stallings RL.MicroRNA-34a functions as a po-tential tumor suppressor by inducing apoptosis in neuroblastomacells[J].Oncogene,2007,26(34):5017-5022.
  • 8Wei CL,Wu Q,Vega VB,et al.A global map of p53 transcription-factor binding sites in the human genome[J].Cell,2006,124(1):207-219.
  • 9Lodygin D,Tarasov V,Epanchintsev A,et al.Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer[J].Cell Cycle,2008,7(16):2591-2600.
  • 10Chen X,Hu H,Guan X,et al.CpG island methylation status ofmiRNAs in esophageal squamous cell carcinoma[J].Int J Cancer,2011 May 5.doi:10.1002/ijc.26171.

共引文献61

同被引文献24

  • 1李文敏.2种化疗方案治疗绒毛膜癌的经济学评价[J].中国药房,2007,18(23):1769-1770. 被引量:4
  • 2Palmer JE,Hancock BW,Tidy JA.Influence of age as a factor in the outcome of gestational trophoblastic neoplasia[J].J Reprod M ed,2008,53(8):565-574.
  • 3Salehi S,Eloranta S,Johansson AL,et al.Reporting and incidence trends of hydatidiform mole in Sw eden 1973-2004[J].Acta Oncol,2011,50(3):367-372.
  • 4Braun-Parvez L,Charlin E,Caillard S,et al.Gestationalchoriocarcinoma transmission follow ing multiorgan donation[J].Am J Transplant,2010,10(11):2541-2546.
  • 5Chalouhi GE,Golfier F,Soignon P,et al.Methotrexate for2000 FIGO low-risk gestational trophoblastic neoplasia patients:efficacy and toxicity[J].Am J Obstet Gynecol,2009,200(6):643,e1-e6.
  • 6Bianconi MI,Otero S,Moscheni O,et al.Gestational trophoblastic disease:a 21-year review of the clinical experience at an Argentinean public hospital[J].J Reprod M ed,2012,57(7-8):341-349.
  • 7Nagy B,Molnar J,Rovo L,et al.Effective chemoradiotherapy w ithout additive toxicity in locoregionally advanced head and neck cancer[J].Anticancer Res,2003,23(5):4329-4332.
  • 8Feng F,Xiang Y.Surgical management of chemotherapy-resistant gestational trophoblastic neoplasia[J].Expert Rev Anticancer,2010,10(1):71-80.
  • 9Buza N, Hui P. hnmunohistochemistry and other ancillary techniques in the diagnosis of geslational trophoblastic disea- ses [J].Semin Diagn Pathol, 2014, 31 (3): 223-232.
  • 10Ad'inan N, Sait K, Salt H. Gestational trophoblastie disease in the western region of Saudi Arabia ( single-institute experi- ence ) [J]. Eur .JObstet Gyneeol Reprod Biol, 2014, 1 g0 : g - ll.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部